Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Cancer vaccine could boost the effectiveness of immunotherapy
Supercharging the mutation rate in cancer cells can create a powerful vaccine that is able…
Brain tumour surgery that pushes boundaries boosts patients survival
Survival may more than double for adults with glioblastoma, the most common and deadly type…
Unprecedented exploration generates most comprehensive map of cancer genomes to date
An international team has completed the most comprehensive study of whole cancer genomes to date,…
Why placebos for chemotherapy side effects are hard to swallow
By Nial Wheate, University of Sydney and Betty Chaar, University of Sydney. It’s unthinkable to give a placebo to someone…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.